Seeking Alpha

NKTR
  Nektar Therapeutics - NASDAQ

8/20/2014, 11:44 PM ET
52wk high:  
52wk low:  
EPS:  
PE (ttm):  
Div Rate:  
Yield:  
Market Cap:  
Volume:  
NKTR vs. ETF Alternatives
Company Description
Nektar Therapeutics, Inc., is a clinical-stage biopharmaceutical company developing a pipeline of drug candidates that utilize its PEGylation and polymer conjugate technology platforms, which are designed to improve the benefits of drugs for patients.
Sector: Healthcare
Industry: Biotechnology
Country: United States